Utility of the F98 rat glioma model for photodynamic therapy

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 26, Issue 2, 2007, Pages 149-155

  Madsen, Steen J ^a   Kharkhuu, Khishigzaya ^a   Hirschberg, Henry ^a,b  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 aminolevulinic acid; ALA; F98 rat glioma; PDT; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN TUMOR; CANCER MODEL; CONFERENCE PAPER; CONTROLLED STUDY; EDEMA; FLUORESCENCE; GLIOMA CELL; HISTOLOGY; INOCULATION; LIGHT EXPOSURE; LIGHT IRRADIANCE; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; TUMOR GROWTH;

ANIMALIA; RATTUS;

EID: 34548098391     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v26.i2.100     Document Type: Conference Paper

References (17)

1. Behin A, Hoang-Xuan K, Carpenter AF, Delattre JY. Primary brain tumours in adults. Lancet. 2003;361:323-31.
2. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatments for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989;16:1405-9.
3. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Review: photodynamic therapy. J Nat Can Inst. 1998;90:889-905.
4. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky K-E, Nesland JM. 5-aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer. 1997;79:2282-308.
5. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg. 1998;16:81-92.
6. Madsen SJ, Sun C-H, Tromberg BJ, Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neurooncol. 2003;62:243-50.
7. Bisland SK, Lilge L, Lin A, Rusnov R, Wilson BC. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol. 2004;80:22-30.
8. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol. 1998;36:91-102.
9. Biston M-C, Joubert A, Adam J-F, Elleaume H, Bohic S, Charvet A-M, Esteve F, Foray N, Balosso J. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron x-rays. Cancer Res. 2004;64:2317-23.
10. Kobayashi N, Allen N, Clendenon NR, Ko L. An improved rat brain-tumor model. J Neurosurg. 1980;53:808-15.
11. Ko L, Koestner A, Wechsler W. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol. 1980;51:23-31.
12. Madsen SJ, Angell-Petersen E, Spetalen S, Carper SW, Ziegler SA, Hirschberg H. ALA-PDT of glioma cell micro-clusters in BD-IX rat brain. Proc SPIE. 2006;6078:Y1-Y8.
13. Madsen SJ, Sun C-H, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol. 2000;72:128-34.
14. Madsen SJ, Angell-Petersen E, Spetalen S, Carper SW, Ziegler SA, Hirschberg H. Photodynamic therapy of newly implanted glioma cells in the rat brain. Lasers Surg Med. 2006;38:540-8.
15. Moor AC, Lagerberg JW, Tijssen K, Foley S, Truscott TG, Kochevar IE, Brand A, Dubbelman TM, VanSteveninck J. In vitro fluence rate effects in photodynamic reactions with AlPcS4 as sensitizer. Photochem Photobiol. 1997;66:860-5.
16. Kunz L, MacRobert AJ. "Intracellular photobleaching of 5, 10, 15 20-Tetrakis (m-hydroxyphenol) chlorine (Foscan) exhibits a complex dependence on oxygen level and fluence rate. Photochem Photobiol. 2002;75:28-35.
17. Ito S, Rachinger W, Stepp H, Reulen HJ, Stummer W. Oedema formation in experimental photoirradiation therapy of brain tumours using 5-ALA. Acta Neurochir (Wien). 2005;147:57-65.